Phase Inversion Temperature Method Research Articles

Multi-charged nanoemulsion for photodynamic treatment of glioblastoma cell line in 2D and 3D in vitro models

Multi-charged nanoemulsions (NE) were designed to deliver Cannabidiol (CBD), Indocyanine green (ICG), and Protoporphyrin (PpIX) to treat glioblastoma (GBM) through Photodynamic Therapy (PDT). The phase-inversion temperature (PIT) method resulted in a highly stable NE that can be scaled easily, with a six-month shelf-life. We observed the quasi-spherical morphology of the nanoemulsions without any unencapsulated material and that 89% (± 5.5%) of the material was encapsulated. All physicochemical properties were within the expected range for a nanostructured drug delivery system, making these multi-charged nanoemulsions promising for further research and development. NE-PIC (NE-Protoporphyrin + Indocyanine + CBD) was easily internalized on GBM cells after three hours of incubation. Nanoemulsion (NE and NE-PIC) did not result in significant cytotoxicity, even for GBM or non-tumorigenic cell lines (NHF). Phototoxicity was significantly higher for the U87MG cell than the T98G cell when exposed to: visible (430 nm) and infrared (810 nm) laser light, with a difference of about 20%. From 50 mJ.cm−2, the viability of GBM cell lines decreases significantly, ranging from 65% to 85%. The NE-PIC was also effective for inhibiting cell proliferation into a 3D spheroidal GBM cell model, which is promising for mimicking the tumor cell environment. Irradiation at 810 nm was more effective in treating spheroid due to its deeper penetration in complex structures. NE-PIC has the potential as a drug delivery system for photoinactivation and photo diagnostic of GBM cell lines, taking advantage of the versatility of its active components.

Ultrasmall Solid-Lipid Nanoparticles via the Polysorbate Sorbitan Phase-Inversion Temperature Technique: A Promising Vehicle for Antioxidant Delivery into the Skin.

Solid lipid nanoparticles promote skin hydration via stratum corneum occlusion, which prevents water loss by evaporation, and via the reinforcement of the skin's lipid-film barrier, which occurs through the adhesion of the nanoparticles to the stratum corneum. The efficacy of both phenomena correlates with lower nanoparticle size and the increased skin permeation of loaded compounds. The so-called Polysorbate Sorbitan Phase-Inversion Temperature method has, therefore, been optimized in this experimental work, in order to engineer ultrasmall solid-lipid nanoparticles that were then loaded with α-tocopherol, as the anti-age ingredient for cosmetic application. Ultrasmall solid-lipid nanoparticles have been proven to be able to favor the skin absorption of loaded compounds via the aforementioned mechanisms.

Effects of Surfactant Characteristics on Fuel Properties of Emulsions of Alternative Engine Fuel through the Phase Inversion Method

Emulsions that mix two or more immiscible phases are broadly applied in pharmaceutics, chemistry, and industries. The phase inversion temperature (PIT) method is an emulsifying approach to preparing an emulsion with low energy consumption and cheap equipment. The effects of surfactant characteristics and processes of cooling or heating on the fuel properties of emulsions composed of silicone oil by the emulsifying method, such as mean droplet sizes of the de-ionized water phase, were considered herein. The application of the silicone oil emulsion as engine fuel was first evaluated. The results show that the emulsions added with the polyol surfactant mixture appeared to have a larger mean water-droplet size, a larger number of dispersed water droplets, a wider range of dispersed-water sizes, and lower kinematic viscosity than those with Brij 30 surfactant. Increasing the surfactant concentration of either Tween 20 mixed with Span 80 or Brij 30 surfactant increased kinematic viscosity and the number of dispersed droplets while decreasing mean droplet sizes. After being subjected to fast heating and then fast cooling, the silicone oil emulsion appeared to form many smaller dispersed droplets than those being proceeded with slow cooling. The emulsion of silicone oil was found to have adequate engine fuel properties.

Design of Extended Bisphosphonate-Based Coordination Polymers as Bone-Targeted Drug Delivery Systems for Breast Cancer-Induced Osteolytic Metastasis and Other Bone Therapies.

The coordination between benzene 1,4-bis(bisphosphonic acid) (BBPA), the bisphosphonate (BP) analogue of benzene 1,4-dicarboxylic acid (BDC), and bioactive metals led to the formation of extended bisphosphonate-based coordination polymers (BPCPs). Four distinct crystalline phases were obtained, namely, BBPA-Ca forms I and II, BBPA-Zn, and BBPA-Mg. Among these, BBPA-Ca forms I (7 × 9 Å2) and II (8 × 12 Å2) possess channels large enough to encapsulate 5-fluorouracil (5-FU), a drug prescribed in combination with BPs to treat breast cancer-induced osteolytic metastases (OM). Dissolution curves show a 14% release of BBPA from BBPA-Ca form II in phosphate-buffered saline, while ∼90% was released in fasted-state simulated gastric fluid. These results suggest that this material is relatively stable in neutral environments yet collapses in acidic conditions. Moreover, the phase inversion temperature method decreased the particle size of BBPA-Ca form II, resulting in nano-Ca@BBPA (∼134 d.nm). Binding assays showed a higher affinity of nano-Ca@BBPA (∼97%) to hydroxyapatite than BBPA (∼70%) and significantly higher binding than commercial BPs, zolendronic (3.0×), and risedronic (2.4×) acids after 24 h. Furthermore, both BBPA-Ca form II and nano-Ca@BBPA presented comparable drug loading and release (∼30 wt % 5-FU) relative to BDC-based CCs (UiO-66, MIL-53, and BDC-Zr) where other pharmaceutical compounds (caffeine, ibuprofen, aspirin, and α-cyano-4-hydroxycinnamic acid) have been encapsulated. Cell viability assays established that drug-loaded nano-Ca@BBPA increases the cytotoxicity of a triple-negative human breast cancer cell line (MDA-MB-231) when compared to 5-FU (%RCV = 8 ± 5 vs 75 ± 1% at a 100 μM). At the same concentration, no significant decrease in cell viability was observed for normal human osteoblast-like hFOB 1.19 cells (%RCV = 85 ± 1%). Collectively, these results demonstrate the feasibility of nano-Ca@BBPA as a potential drug delivery system (DDS), with high affinity to bone tissue, to treat bone-related diseases such as OM.

Topical delivery of mupirocin calcium nanostructured lipid carriers using a full-thickness excision wound healing model

Treatment of contaminated wounds represents a significant challenge in healthcare and there is a need to develop approaches maximising skin retention to maintain therapeutic concentrations of anti-infectives at the wound site. The objective of the present study was to develop and evaluate mupirocin calcium nanolipid emulgels to enhance wound healing performance and patient acceptability. Nanostructured lipid carriers (NLCs) of mupirocin calcium were prepared by the phase inversion temperature method using Precirol ATO 5 (Gattefosse, India) and oleic acid as lipids and Kolliphor RH 40 (BASF, India) as surfactant and further incorporated into a gel base for topical delivery. The particle size, polydispersity index and zeta potential of mupirocin NLCs were found to be 128.8±1.25nm, 0.283±0.003 and -24.2±0.56mV, respectively. In vitro release studies from developed emulgel showed sustained drug release over 24 hours. Ex vivo drug permeation studies through excised rat abdominal skin showed better skin permeation (1712.38±15. 57μg/cm2) from developed emulgel compared to marketed ointment (827.92±21.42μg/cm2) after 8 hours, which was in agreement with in vitro antibacterial activity. Studies on Wistar rats indicated the nonirritant potential of developed emulgels. Further, mupirocin emulgels showed improved efficacy in percent wound contraction of acute contaminated open wounds in Wistar rats using a full-thickness excision wound healing model. The emulgels of mupirocin calcium NLCs appear to be effective in the treatment of contaminated wounds due to increased skin deposition and sustained release, thereby enhancing the wound healing potential of existing molecules.

The Influences of Emulsification Variables on Emulsion Characteristics Prepared through the Phase Inversion Temperature Method as Engine Fuel

The effects of emulsification variables, such as surfactant type and heating/cooling emulsion processes, on the emulsification characteristics of silicone oil’s emulsions prepared by the phase inversion temperature method were investigated in this study. The water-in-oil (W/O) emulsions have been widely applied to enhance burning efficiency and reduce both pollutant emissions and fuel consumption. The silicone oil was emulsified with de-ionized water with the assistance of nonionic surfactants to form oil-in-water (O/W) emulsions. The hydrophilic–lipophilic balance (HLB) value of the Span 80 and Tween 20 surfactant mixture was set equal to 10 based on their weight proportions and the respective HLB values of the two surfactants. The experimental results show that the emulsions with the Span 80/Tween 20 surfactant mixture appeared to have a higher phase inversion temperature and a larger electrical conductance. On the other hand, it has a lower emulsification stability and a narrower range of phase inversion temperature than the emulsions prepared with a Brij 30 surfactant (polyoxyethylene (4) lauryl ether). The increase in surfactant concentration from 1 wt.% to 10 wt.% decreased the electrical conductance and phase inversion temperature while increasing the suspensibility and absorbance value for the emulsions prepared with either Span 80/Tween 20 mixture or Brij 30.

Comparison of the Engine Performance of Soybean Oil Biodiesel Emulsions Prepared by Phase Inversion Temperature and Mechanical Homogenization Methods

The engine performance and emission characteristics of burning emulsions of soybean oil biodiesel in a compression-ignition diesel engine prepared through the phase inversion temperature method were compared with those of neat soybean oil biodiesel and the emulsion prepared by the mechanical homogenization method. The engine torque was set constantly at 98 N·m with varying engine speeds. The experimental results show that the emulsion prepared by the method of phase inversion temperature had higher O2 and NOx emissions, a higher excess air ratio, a higher exhaust gas temperature, and a higher brake fuel conversion efficiency than the emulsion prepared by the mechanical homogenization method, which had lower CO and CO2 emissions, a lower equivalence ratio, and lower brake-specific fuel consumption. While the neat soybean oil biodiesel was found to have the lowest fuel consumption rate, brake-specific fuel consumption, and CO and CO2 emissions, it had the highest exhaust gas temperature and brake fuel conversion efficiency, NOx and O2 emissions, and excess air ratio among those three fuels. Therefore, the phase inversion temperature method is considered promising for preparing fuel emulsions as an alternative to petro-derived diesel for compression-ignition engines.

Enhancing the stability, BBB permeability and neuroprotective activity of verbascoside in vitro using lipid nanocapsules in combination with menthol

Verbascoside (VER) shows promising neuroprotective activity. However, the instability and low permeability in crossing the blood–brain barrier (BBB) greatly hinder its application. In the present study, verbascoside was encapsulated into lipid nanocapsules (LNC) by reverse micelle (RM) to increase its stability. Besides, we used VER-RM-LNC combined with an envoy drug, menthol, to improve its BBB permeability and neuroprotective activity. VER-RM-LNC was prepared by the phase inversion temperature method, resulting in an encapsulation efficiency of nearly 85 %. The formulated VER-RM-LNC was stable for 6 months at 4 °C. VER encapsulated into LNC possessed enhanced stability and a reduced release profile. Menthol increased the cellular uptake and the permeability of VER-RM-LNC in the BBB model in vitro. In addition, the improved neuroprotective activity of VER through incubation with menthol and VER-RM-LNC was verified in the neurotoxic human brain microvascular endothelial cells model induced by Aβ25-35.

Characterisation and microbial activity of neem oil nano-emulsions formulated by phase inversion temperature method

This study has been carried out to prepare neem oil-in-water nano-emulsions stabilized by Brij 30 surfactant using the phase inversion temperature (PIT) method at three different temperatures, i.e., 60, 75 and 80°C. Compositions of homogenous phase have been identified in the pseudo-ternary phase diagram. Among the total seventeen formulations, three formulations (NB1, NB2 and NB3) have been short-listed and characterized for emulsion size and viscosity. The selected formulations have shown emulsion size of 348-981 nm in diameter. The volume percentage ratio of Brij 30 to neem oil have shown significant effect on the droplet size of nano-emulsions. Formulations having lower concentration of Brij 30 have displayed a smaller emulsion droplet size (348 nm). The NB3 formulation (4% neem oil, 11% Brij 30 and 85% deionized water) has exhibited the highest stability after 60 days of storage. Antimicrobial study has shown that in contrast to raw neem and Ampicillin (synthetic drug), NB1 exhibited best result in terms of minimum inhibition concentration (MIC) reduction by 100% against E-coli, P. aeruginosa, S. aureus and S. pyogenus.

Lipid nanocapsules enhance the transdermal delivery of drugs regardless of their physico-chemical properties

The transdermal application of actives offers numerous advantages over other conventional routes. Namely, a stable level of drugs in the bloodstream and reduced side effects are the argument for topical administration. Unfortunately, the exceptional skin barrier and unsuitable physico-chemical properties of drugs are the limiting factors for the transdermal passage. It is possible to overcome this by incorporating the drug into nano-carriers to enhance its permeation through the skin barrier. For this purpose, we prepared lipid nanocapsules (LNCs) to modulate skin passage of three pharmaceutically important drugs – indomethacin (IND), diclofenac sodium (DF) and caffeine (CF). We present a stable system prepared by the phase inversion temperature method with particle size under 100 nm and PDI < 0.1 with great encapsulation efficiency for indomethacin and diclofenac. By FTIR it was possible to confirm (for IND and DF) or disprove (in case of CF) the incorporation of a drug into the LNCs. By ex vivo permeation experiments on porcine skin, we confirmed the superior effect of the LNCs on the APIs skin passage. The drug permeated through the skin with higher intensity when delivered from LNCs compared to other standard formulations. We show that lipid nanocapsules play an important role in enhanced topical application of actives.

Role of solid lipid nanoparticle for the delivery of Lipophilic Drugs and Herbal Medicines in the treatment of pulmonary hypertension.

Pulmonary arterial hypertension (PAH) is an uncommon condition marked by elevated pulmonary artery pressure that leads to right ventricular failure. The majority of drugs are now been approved by FDA for PAH, however, several biopharmaceutical hindrances lead to failure of the therapy. Various novel drug delivery systems are available in the literature from which lipid-based nanoparticles i.e. solid lipid nanoparticle is widely investigated for improving the solubility and bioavailability of drugs. In this paper, the prototype phytoconstituents used in pulmonary arterial hypertension have limited solubility and bioavailability. We highlighted the novel concepts of SLN for lipophilic phytoconstituents with their potential applications. This paper also reviews the present state of the art regarding production techniques for SLN like High-Pressure Homogenization, Micro-emulsion Technique, and Phase Inversion Temperature Method, etc. Furthermore, toxicity aspects and in vivo fate of SLN are also highlighted in this review. In a nutshell, safer delivery of phytoconstituents by SLN added a novel feather to the cap of successful drug delivery technologies.

New Approach for Preparing Solid Lipid Nanoparticles with Volatile Oil-Loaded Quercetin Using the Phase-Inversion Temperature Method.

Quercetin (QCT), a natural flavonoid, is of research interest owing to its pharmacological properties. However, its pharmacokinetic limitations could hinder its widespread therapeutic use. Nanocarriers, especially solid lipid nanoparticles (SLNs), might overcome this constraint. This study aimed to investigate QCT-loaded SLNs prepared via a new approach using a volatile oil. The phase-inversion temperature method was used to incorporate rosemary oil (RMO) into SLNs prepared using solid lipids possessing different chemical structures. Among the solid lipids used in the formulations, trilaurin (TLR) exhibited the smallest particle size and good stability after a temperature cycling test. SLNs prepared with a ratio of RMO to TLR of 1:3 could load QCT with an entrapment efficiency of >60% and drug loading of ~2% w/w. The smallest particle size was achieved using the polyoxyethylene-hydrogenated castor oil RH40, and the particle size depended on the concentration. The drug-release profile of QCT_TLR exhibited prolonged biphasic release for >24 h. QCT_TLR was a safe formulation, as indicated by a cell viability percentage of >75% at <2% v/v. In a computer simulation, the system with RMO enabled smaller sized SLNs than those without RMO. This new discovery shows great promise for producing SLNs via the phase-inversion temperature method with incorporation of volatile oil, particularly for delivering compounds with limited water solubility.

Characterization and Interaction with Biomembrane Model of Benzo[k,l]xanthene Lignan Loaded Solid Lipid Nanoparticles.

Benzo[k,l]xanthene lignans are a group of rare natural products belonging to the class of polyphenols with promising biological activities and are studied as potential chemotherapeutic agents. The lipophilic character of a xanthene core makes these molecules difficult to be used in an aqueous medium, limiting their employment in studies for pharmaceutical applications. To overcome this problem, a drug-delivery system which is able to improve the stability and bioavailability of the compound can be used. In this study, a bioactive benzoxanthene lignan (BXL) has been included in SLN. Unloaded and BXL-loaded SLN have been prepared using the Phase Inversion Temperature method and characterized in terms of size, zeta potential, entrapment efficiency and stability. Differential scanning calorimetry was used to evaluate the thermotropic behavior and ability of SLN to act as carriers for BXL. A biomembrane model, represented by multilamellar vesicles, was used to simulate the interaction of the SLN with the cellular membrane. Unloaded and loaded SLN were incubated with the MLV, and their interactions were evaluated through variations in their calorimetric curves. The results obtained suggest that SLN could be used as a delivery system for BXL.

Estimating Preferred Alkane Carbon Numbers of Nonionic Surfactants in Normalized Hydrophilic-Lipophilic Deviation Theory from Dissipative Particle Dynamics Modeling.

The preferred alkane carbon number (PACN) in the normalized hydrophilic-lipophilic deviation (HLDN) theory is a numerical parameter and a transferable scale to characterize the amphiphilicity of surfactants, which is usually measured experimentally using the fish diagram or phase inversion temperature (PIT) methods, and the experimental measurement can only be applied to existing surfactants. Here, for the first time, we propose a procedure to estimate the PACN of CiEj nonionic surfactants directly from dissipative particle dynamics (DPD) simulation. The procedure leverages the method of moment concept to quantitatively evaluate the bending tendency of nonionic surfactant monolayers by calculating the torque density. Seven nonionic surfactants, CiEj (C6E2, C6E3, C8E3, C8E4, C10E4, C12E4, and C12E5), with known PACNs are modeled. Two surfactants, C10E4 and C6E2, were first selected to train and test the interaction parameters, and the relationship between interaction parameters and torque density was mapped for the C10E4-octane-water system using the artificial neural network (ANN) fitting approach to derive the interaction parameters giving zero torque density, then the interaction parameters were tested in the C6E2-dodecane-water system to get the final tuned interaction parameters for PACN estimation. With this procedure, we reproduce the PACN values and their trend of seven nonionic surfactants with reasonable accuracy, which opens the door for quantitative comparison of surfactant amphiphilicity and surfactant classification in silico using the PACN as a transferrable scale.

Impact of Fixed Oil on Ostwald Ripening of Anti-Oral Cancer Nanoemulsions Loaded with Amomum kravanh Essential Oil.

Recently, essential oil from Amomum kravanh (AMO) was reported to exert anti-oral cancer effects. Although it was more effective after being loaded into nanoemulsions, AMO without an Ostwald ripening inhibitor was unable to form stable nanoemulsions because of the Ostwald ripening phenomenon. In this study, we examined the influence of Ostwald ripening inhibitors, such as fixed oils and polyethylene glycol 4000 (PEG 4000), on nanoemulsion properties prepared by a phase inversion temperature method. Several fixed oils, including virgin coconut oil (VCO), palm oil (PMO), olive oil (OLO), and PEG 4000, were evaluated, and their Ostwald ripening inhibitory effects were compared. The results suggest that the type and ratio of AMO:fixed oils influence the formation and characteristics of nanoemulsions. PEG 4000 was unable to produce nanoemulsions; however, stable nanoemulsions with small droplet sizes were observed in preparations containing OLO and VCO at an AMO:fixed oil ratio of 80:20, which may be the result of specific molecular interactions among the components. Using an MTT assay, we demonstrated that the AMO:OLO (80:20) nanoemulsion produced the most significant cytotoxic effect on oral cancer cells with a percentage of 99.68 ± 0.56%. Furthermore, the AMO:OLO 80:20 nanoemulsion inhibits metastasis and induces oral cancer cell death through the intrinsic apoptosis pathway. In conclusion, AMO nanoemulsion with anti-oral cancer activity was successfully produced by varying the amount and type of fixed oils. In the future, this discovery may lead to the development of stable nanoemulsions employing additional volatile oils.

Anticancer Activity of Nanoemulsions Loading Biomaterial &lt;i&gt;Amomum kravanh&lt;/i&gt; Oil against Oral Cancer Cells

Several biomaterial presented anticancer activities including volatile oil. Interestingly, the volatile oil from Amomum kravanh has been reported as anticancer activity. Nevertheless, the utilization in native oil might be barrier to apply its as anticancer agent because of the limitation of their water solubility. One of the solutions to this challenge is to use nanoemulsions as a carrier for delivery A.kravanh oil (AMO) into oral cancer cell. In this research, the phase inversion temperature method was used to prepared nanoemulsions containning AMO. The physical and anticancer property of various nanoemulsions were comparatively evaluated. The 8AMO:2Soybean oil (SBO) illustrated spherical and small oil droplet around 80 nm. It also presented good physical stability after temperature cycling test. Regarding anticancer property, the 8AMO:2SBO can considerably arrest oral cancer cells with dose dependent manner at IC50 of 0.76% v/v, and the nuclear fragmentation that was remarkable feature of apoptosis was also found in 8AMO:2SBO group. This discovery demonstrated that the AMO loaded nanoemulsions system can be consider to alternative choices for oral cancer prevention and treatment.

Solid lipid nanoparticles loaded with curcumin: development and in vitro toxicity against CT26 cells.

Aim: To develop a new curcumin carrier consisting of murumuru butter nanoparticles (SLN-Cs). Methods: A phase-inversion temperature method was used to produce SLN-Cs. The interaction of SLN-Cs with murine colon adenocarcinoma (CT26) cells in vitro was analyzed by confocal microscopy. Results: Stable SLN-Cs with a high curcumin-loading capacity were obtained. TheSLN-Cs were more toxicto CT26than free curcumin. Fluorescence microscopy images showed the SLN-Cs to be taken up by CT26 cells in vitro. Conclusion: These results indicate that SLN-Cs are suitable carriers of curcumin in aqueous media.

Solid lipid nanoparticles and nanoemulsions with solid shell: Physical and thermal stability

HypothesisNanoemulsions (NE) and solid lipid nanoparticles (SLN) used for drug delivery should have a solid shell to be stable during long shelf life and become liquid at human body temperature. The core components of lipid nanoparticles can be partially incorporated into the shell and affect the physical and thermal stability. ExperimentsWe prepared NE and SLN by the phase inversion temperature (PIT) method. Solidification of the surfactants Tween60 and Span 60 on the surface of NE droplets with paraffin oil resulted in the formation of the solid shell. SLN contained stearic acid in the core and the same surfactants in the solid shell. The size, structure and stability of the NE and SLN were studied by DLS and cryo-TEM. Their crystallization and melting were analyzed using DSC. FindingsThe lipid nanoparticles were resistant to aggregation and sedimentation and hold up to at least two cycles of heating to 50–60 °C and subsequent cooling to 5 °C, even though the upper temperatures were higher than the melting point of the surfactant shell. The expected liquid core/solid shell morphology of NE was confirmed. SLN were composed of a semi-liquid core of supercooled stearic acid melt and coated with a solid surfactant shell, so they can be treated as NE. Stearic acid molecules penetrated the shell, leading to an increase in its melting point.

Solid Lipid Nanoparticles as Carriers for the Synthetic Opioid LP2: Characterization and In Vitro Release

A synthetic dual-target mu opioid peptide receptor/delta opioid peptide receptor anti-nociceptive ligand, named LP2, has emerged as a promising candidate for the management of acute and/or persistent pain, but its lipophilicity limits further developments as a therapeutic agent. In this work, to allow designing aqueous formulations of LP2 for parenteral administration, solid lipid nanoparticles (SLNs) were investigated as LP2 nanocarriers. LP2-loaded SLNs were prepared by the phase-inversion temperature method, showing good technological properties (small mean particle, size, low polydispersity index, good stability). As LP2 was a diastereoisomeric mixture of 2R/2S-LP2, an HPLC method was developed to identify and quantify each diastereoisomer, and this method was used to assess LP2 in vitro release from SLNs. The developed method, based on reverse-phase chromatography using an isocratic mobile phase consisting of 50% methanol and 50% triethanolamine at 0.3% (pH = 3 with trifluoroacetic acid), allowed efficient separation of 2R- and 2S-LP2 peaks and reliable quantification with intra- and inter-day precision and accuracy within the acceptability limit, expressed as relative standard deviation set at ≤15%. The results of this study suggest that the incorporation of LP2 into SLNs could be a promising strategy to design suitable formulations for further pharmacological studies involving LP2.

Development and optimization of drug-loaded nanoemulsion system by phase inversion temperature (PIT) method using Box–Behnken design

Objective The objective of the present investigation was to develop a stable and optimized drug-loaded nanoemulsion system using the phase inversion temperature (PIT) method. Significance The PIT method has been widely used for the development of food-grade nanoemulsion systems. For the first time, a simple and cost-effective, PIT method was used for the development of a stable drug-loaded nanoemulsion system. Methods Box–Behnken experimental design was used for the development of an optimized drug-loaded nanoemulsion system by the PIT method. The independent variables were optimized for responses by using the desirability function. The hydrophobic drug, benidipine was used as a modal drug. Optimized oil phase (blend of long-chain triglycerides oil, medium-chain triglycerides oil and essential oil) was used for the development of oil in water (O/W) nanoemulsion system. Results Optimum nanoemulsion formulation was stable, transparent and contained 50% of oil to surfactant percentage with a droplet size of 96.57 ± 1.61 nm. The optimum formulation also showed higher in-vitro drug diffusion from dialysis membrane as compared to the marketed formulation. Nanoemulsion droplets were observed as spherical in the transmission electron microscopy (TEM) images. Box-Behnken statistical analysis revealed that all the independent variables had a significant impact on characteristics of nanoemulsion and the predicated value of independent variables was found to be valid. Conclusion It was concluded that the PIT method produces a stable and efficient drug-loaded nanoemulsion system. Further, the optimized oil phase can be used as an alternative to costly, commercial medium-chain triglycerides (MCT) oils, for the development of a stable nanoemulsion system.